The proportion of IFN-γ-secreting CTLs in tumor tissue increased by about 1.7-fold from around 15.6% with α-PD-1 alone to 26.7% when administered in combination with Mφ-SDNP (Fig. 4I). This evidence concerns the gene IFNG and neoplasm.